Skip to main content
Premium Trial:

Request an Annual Quote

QTL Biosystems Lightspeed and EMD Biosciences Signal Transduction Interactive Pathways


QTL Biosystems has announced four new additions to its Lightspeed fluorescence-based kinase and protease assays: PKC-alpha (diabetes and leukemia screening), Akt-1 (cancer), Src (cancer), and p38-alpha (leukemia and lymphoma). QTL said the homogenous assays, which can be read with most commercially available fluorescence spectrometers and multiwell plate readers, are scalable from 96- to 3,456-well formats, and feature limits of detection in the picomolar range.

EMD Biosciences, a part of Merck KgaA’s Life Science and Analytics division, has released several new Signal Transduction Interactive Pathways on its website. The Interactive Pathways provide researchers with graphical tools that depict known interactions that occur in cell signaling and can affect disease development, EMD said. Clicking on a component of a pathway displays information about related EMD products, including antibodies, inhibitors, enzymes, proteins, enzyme substrates, and kits, the company said.


The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.